LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study

Authors: Laurence Albigès, Brian I. Rini, Katriina Peltola, G.A. De Velasco Oria, Mauricio Burotto, C. Suarez Rodriguez, Pooja Ghatalia, Roberto Iacovelli, Elaine T. Lam, Elena Verzoni, M. Gumus, Walter M. Stadler, Christian Kollmannsberger, Bohuslav Melichar, B. Venugopal, Andrew Z. Wang, R. Perini, Donna Vickery, T.B. Powles, Toni K. Choueiri - Annals of Oncology 2023 cited by 53